Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 5, 2003

 


 

NovaMed Eyecare, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   0-26625   36-4116193

(State or Other

Jurisdiction of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

980 North Michigan Avenue, Suite 1620, Chicago, Illinois   60611
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (312) 664-4100

 


 


Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits.

 

(c) Exhibits

 

Exhibit Number

  

Title


99.1    Press release of NovaMed Eyecare, Inc. dated November 5, 2003

 

Item 12.   Results of Operations and Financial Condition.

 

The following information is furnished pursuant to Item 12. “Results of Operations & Financial Condition” in accordance with SEC Release No. 33-8216.

 

On November 5, 2003, NovaMed Eyecare, Inc. issued a press release announcing its results of operations for the period ended September 30, 2003. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

 

The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 


SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

NovaMed Eyecare, Inc.

Dated: November 5, 2003

      By:  

/s/    Stephen J. Winjum        


               

Stephen J. Winjum

President and Chief Executive Officer

 


EXHIBIT INDEX

 

Exhibit No.

  

Exhibit


99.1    Press Release of NovaMed Eyecare, Inc. dated November 5, 2003.